Digoxin: Revision history

18 August 2015

• curprev 19:5619:56, 18 August 2015‎ WikiBot talk contribs‎ m 49,661 bytes 0‎ Changed protection level for "Digoxin": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))

25 May 2015

• curprev 08:2208:22, 25 May 2015‎ Gerald Chi- talk contribs‎ m 49,661 bytes +19‎ No edit summary
• curprev 08:2108:21, 25 May 2015‎ Gerald Chi- talk contribs‎ m 49,642 bytes +28‎ No edit summary

23 July 2014

• curprev 21:3021:30, 23 July 2014‎ GeraldChi talk contribs‎ 49,614 bytes −1‎ No edit summary
• curprev 21:2921:29, 23 July 2014‎ GeraldChi talk contribs‎ 49,615 bytes +1‎ No edit summary
• curprev 15:1215:12, 23 July 2014‎ Alonso Alvarado talk contribs‎ 49,614 bytes −8,258‎ No edit summary
• curprev 14:3114:31, 23 July 2014‎ Alonso Alvarado talk contribs‎ 57,872 bytes −46‎ →‎Administration
• curprev 14:2914:29, 23 July 2014‎ Alonso Alvarado talk contribs‎ 57,918 bytes +86‎ No edit summary

1 April 2014

• curprev 15:2415:24, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 57,832 bytes +263‎ No edit summary
• curprev 15:0215:02, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 57,569 bytes −2‎ →‎Patient Information from FDA
• curprev 14:5614:56, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 57,571 bytes −21‎ →‎FDA-Labeled Indications and Dosage (Pediatric)
• curprev 14:5414:54, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 57,592 bytes −67‎ →‎FDA-Labeled Indications and Dosage (Adult)
• curprev 14:4714:47, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 57,659 bytes +861‎ →‎Patient Information
• curprev 14:4314:43, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 56,798 bytes +222‎ →‎Images
• curprev 14:3814:38, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 56,576 bytes +14‎ →‎How Supplied
• curprev 14:2914:29, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 56,562 bytes +28‎ →‎Drug Images
• curprev 14:2814:28, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 56,534 bytes +18‎ →‎How Supplied
• curprev 14:2714:27, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 56,516 bytes +877‎ →‎How Supplied
• curprev 14:1614:16, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,639 bytes +8‎ →‎FDA-Labeled Indications and Dosage (Adult)
• curprev 14:1414:14, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,631 bytes +56‎ →‎FDA-Labeled Indications and Dosage (Pediatric)
• curprev 13:5613:56, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,575 bytes +4‎ →‎FDA-Labeled Indications and Dosage (Adult)
• curprev 13:5413:54, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,571 bytes +9‎ →‎FDA-Labeled Indications and Dosage (Adult)
• curprev 13:4713:47, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,562 bytes +80‎ →‎Images
• curprev 13:4213:42, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,482 bytes −561‎ →‎Off-Label Use and Dosage (Adult)
• curprev 13:3813:38, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 56,043 bytes +270‎ →‎Package and Label Display Panel
• curprev 13:2713:27, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 55,773 bytes +1,772‎ →‎Drug Interactions
• curprev 13:2513:25, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 54,001 bytes −1‎ →‎Drug Interactions
• curprev 13:2413:24, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 54,002 bytes +843‎ →‎Drug Interactions
• curprev 13:1513:15, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 53,159 bytes +2,660‎ →‎Administration
• curprev 13:0313:03, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 50,499 bytes +5‎ →‎Management
• curprev 13:0113:01, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 50,494 bytes +9‎ →‎Management
• curprev 12:5612:56, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 50,485 bytes +16‎ →‎Acute Overdose
• curprev 12:5412:54, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 50,469 bytes +65‎ →‎Nonclinical Toxicology
• curprev 12:5212:52, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 50,404 bytes −289‎ →‎Off-Label Use and Dosage (Pediatric)
• curprev 12:5012:50, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 50,693 bytes −1,201‎ →‎IV Compatibility
• curprev 12:4912:49, 1 April 2014‎ Abdurahman Khalil talk contribs‎ 51,894 bytes +2,825‎ →‎Clinical Studies

31 March 2014

• curprev 21:1221:12, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 49,069 bytes +6‎ →‎Drug Images
• curprev 21:0621:06, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 49,063 bytes +24‎ →‎Drug Images
• curprev 20:5020:50, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 49,039 bytes +59‎ →‎Patient Information from NLM
• curprev 20:3720:37, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 48,980 bytes +1‎ →‎Structure
• curprev 20:3520:35, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 48,979 bytes −2‎ →‎How Supplied
• curprev 20:3420:34, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 48,981 bytes +1,262‎ →‎How Supplied
• curprev 20:2620:26, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,719 bytes −71‎ →‎Pharmacology
• curprev 20:1920:19, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,790 bytes −2‎ →‎Drug Interactions
• curprev 19:5519:55, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,792 bytes +253‎ →‎Administration and Monitoring
• curprev 19:2419:24, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,539 bytes −121‎ →‎Look-Alike Drug Names
• curprev 19:1619:16, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,660 bytes +17‎ →‎Brand Names
• curprev 19:1219:12, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,643 bytes +140‎ →‎Signs and Symptoms
• curprev 19:1019:10, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 47,503 bytes +852‎ →‎Management
• curprev 19:0919:09, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 46,651 bytes +1,713‎ →‎Management
• curprev 19:0819:08, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 44,938 bytes +3,360‎ →‎Signs and Symptoms
• curprev 19:0519:05, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 41,578 bytes 0‎ →‎Compatible
• curprev 19:0119:01, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 41,578 bytes −6‎ →‎Administration
• curprev 19:0019:00, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 41,584 bytes +1,034‎ →‎Monitoring
• curprev 17:5917:59, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,550 bytes −33‎ →‎Pharmacology
• curprev 17:5817:58, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,583 bytes −11‎ →‎Pharmacology
• curprev 16:4816:48, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,594 bytes +216‎ →‎Contraindications
• curprev 16:3816:38, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 40,378 bytes +1,827‎ →‎Use in Specific Populations
• curprev 16:1616:16, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 38,551 bytes +216‎ No edit summary
• curprev 16:1416:14, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 38,335 bytes −28‎ →‎Mechanism of Action
• curprev 16:1316:13, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 38,363 bytes +9,508‎ →‎Pharmacology
• curprev 15:5315:53, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 28,855 bytes +1,351‎ →‎Patient Information from FDA
• curprev 15:0515:05, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 27,504 bytes +1,460‎ →‎Use in Specific Populations
• curprev 15:0215:02, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 26,044 bytes +2,825‎ →‎Drug Interactions
• curprev 14:5914:59, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 23,219 bytes +1,017‎ →‎Adverse Reactions
• curprev 14:5614:56, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 22,202 bytes +1,622‎ →‎Non–Guideline-Supported Use
• curprev 14:5514:55, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 20,580 bytes +377‎ →‎FDA-Labeled Indications and Dosage (Pediatric)
• curprev 14:4714:47, 31 March 2014‎ Abdurahman Khalil talk contribs‎ 20,203 bytes +779‎ No edit summary

27 March 2014

• curprev 18:5818:58, 27 March 2014‎ Abdurahman Khalil talk contribs‎ 19,424 bytes 0‎ No edit summary
• curprev 18:5718:57, 27 March 2014‎ Abdurahman Khalil talk contribs‎ 19,424 bytes +5,671‎ No edit summary
• curprev 16:5316:53, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,753 bytes +21‎ →‎Overview
• curprev 12:5512:55, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,732 bytes +20‎ →‎Overview
• curprev 12:5412:54, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,712 bytes −1‎ No edit summary
• curprev 12:5312:53, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,713 bytes −20‎ No edit summary
• curprev 12:5312:53, 27 March 2014‎ Gerald Chi talk contribs‎ m 13,733 bytes +12,382‎ No edit summary

26 March 2014

• curprev 17:2217:22, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 1,351 bytes 0‎ No edit summary
• curprev 17:1317:13, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 1,351 bytes −3,183‎ No edit summary
• curprev 17:1217:12, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 4,534 bytes −25‎ →‎Lanoxin (digoxin) tablet
• curprev 17:1017:10, 26 March 2014‎ Abdurahman Khalil talk contribs‎ 4,559 bytes −14‎ No edit summary

25 March 2014

• curprev 15:1815:18, 25 March 2014‎ Abdurahman Khalil talk contribs‎ 4,573 bytes +2‎ No edit summary
• curprev 12:4712:47, 25 March 2014‎ GeraldChi talk contribs‎ 4,571 bytes −57‎ No edit summary
• curprev 12:4612:46, 25 March 2014‎ GeraldChi talk contribs‎ 4,628 bytes −65‎ →‎Category

20 March 2014

• curprev 14:4814:48, 20 March 2014‎ Abdurahman Khalil talk contribs‎ 4,693 bytes +60‎ No edit summary
• curprev 14:4414:44, 20 March 2014‎ Abdurahman Khalil talk contribs‎ 4,633 bytes 0‎ No edit summary
• curprev 14:4214:42, 20 March 2014‎ Abdurahman Khalil talk contribs‎ 4,633 bytes −888‎ No edit summary

28 February 2014

• curprev 16:0116:01, 28 February 2014‎ Abdurahman Khalil talk contribs‎ 5,521 bytes +1,719‎ →‎Mechanism of Action

27 February 2014

• curprev 19:3419:34, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,802 bytes 0‎ No edit summary
• curprev 19:2919:29, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,802 bytes +216‎ →‎References
• curprev 19:2619:26, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,586 bytes +28‎ →‎US Brand Names
• curprev 19:2519:25, 27 February 2014‎ Abdurahman Khalil talk contribs‎ 3,558 bytes +1,368‎ →‎FDA Package Insert

22 February 2014

• curprev 21:0821:08, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,190 bytes +24‎ →‎Category
• curprev 21:0721:07, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,166 bytes +1‎ →‎Overview
• curprev 21:0621:06, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,165 bytes −53‎ →‎Overview
• curprev 21:0421:04, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 2,218 bytes +858‎ →‎Overview
• curprev 20:2420:24, 22 February 2014‎ Abdurahman Khalil talk contribs‎ 1,360 bytes +16‎ No edit summary

29 January 2014

• curprev 23:4523:45, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,344 bytes +54‎ No edit summary
• curprev 23:3923:39, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,290 bytes +34‎ No edit summary
• curprev 23:3823:38, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,256 bytes +15‎ No edit summary
• curprev 23:3823:38, 29 January 2014‎ Ahmed Zaghw talk contribs‎ 1,241 bytes −7,562‎ No edit summary

24 September 2012

• curprev 00:2300:23, 24 September 2012‎ C Michael Gibson talk contribs‎ 8,803 bytes −930‎ No edit summary